These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 342293)

  • 1. Remissions of mycosis fungoides induced by nitrogen mustard (HN2). Topical treatment and hydration of tumours and plaques with HN2. Topical desensitization to HN2. A clinical and histopathological controlled study.
    Volden G; Larsen TE
    Dermatologica; 1978; 156(3):129-41. PubMed ID: 342293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Topical, intratumor and intravenous nitrogen mustard in the treatment of mycosis fungoides (author's transl)].
    Sánchez Yus E; Vanaclocha Sebastián F
    Med Clin (Barc); 1980 Sep; 75(5):199-202. PubMed ID: 6999251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycosis fungoides plaque stage treated with topical nitrogen mustard with and without attempts at tolerance induction: report from the Scandinavian mycosis fungoides study group.
    Molin L; Thomsen K; Volden G
    Acta Derm Venereol; 1979; 59(1):64-8. PubMed ID: 84470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of mycosis fungoides by topical application of nitrogen mustard].
    Waldorf DS
    Hautarzt; 1970 Jul; 21(7):319-20. PubMed ID: 5522289
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical nitrogen mustard induced carcinogenesis.
    Kravitz PH; McDonald CJ
    Acta Derm Venereol; 1978; 58(5):421-5. PubMed ID: 82352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance.
    Van Scott EJ; Kalmanson JD
    Cancer; 1973 Jul; 32(1):18-30. PubMed ID: 4577503
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical nitrogen mustard in mycosis fungoides.
    Zachariae H
    Int J Clin Pharmacol Res; 1985; 5(3):193-8. PubMed ID: 4018954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical nitrogen mustard in early mycosis fungoides. A 12-year experience.
    Zachariae H; Thestrup-Pedersen K; Søgaard H
    Acta Derm Venereol; 1985; 65(1):53-8. PubMed ID: 2578706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mycosis fungoides treated by local administration of a nitrogen mustard preparation, Erasol].
    Grunnet E; Thulin H; Zachariae H
    Ugeskr Laeger; 1975 Mar; 137(11):621-3. PubMed ID: 1145773
    [No Abstract]   [Full Text] [Related]  

  • 10. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides.
    Chinn DM; Chow S; Kim YH; Hoppe RT
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):951-8. PubMed ID: 10192339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivity.
    Constantine VS; Fuks ZY; Farber EM
    Arch Dermatol; 1975 Apr; 111(4):484-8. PubMed ID: 1122150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Milia in regressing plaques of mycosis fungoides: provoked by topical nitrogen mustard or not?
    Kalayciyan A; Oguz O; Demirkesen C; Serdaroglu S; Kotogyan A
    Int J Dermatol; 2004 Dec; 43(12):953-6. PubMed ID: 15569030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycosis fungoides. Topical use of nitrogen mustard in recurrent cases.
    Arundell FD; Chan WH
    Calif Med; 1968 Dec; 109(6):458-61. PubMed ID: 5724878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal contact sensitivity to nitrogen mustard in lesions of cutaneous T-cell lymphoma (mycosis fungoides).
    Shelley WB
    Acta Derm Venereol; 1981; 61(2):161-4. PubMed ID: 6165197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Safe handling of nitrogen mustard. Risks for nurses in the treatment of mycosis fungoides].
    Cooijmans AC; Lensink JG; van Vloten WA
    TVZ; 1993 Feb; (4):143-7. PubMed ID: 8484873
    [No Abstract]   [Full Text] [Related]  

  • 16. Response of mycosis fungoides to topical chemotherapy with mechlorethamine.
    Ramsay DL; Parnes RE; Dubin N
    Arch Dermatol; 1984 Dec; 120(12):1585-90. PubMed ID: 6508330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photochemotherapy (PUVA) in the pretumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
    Molin L; Thomsen K; Volden G; Groth O
    Acta Derm Venereol; 1981; 61(1):47-51. PubMed ID: 6164214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Topical application of ACNU for the treatment of mycosis fungoides].
    Jimbow K; Horikoshi T; Kamimura M
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1231-6. PubMed ID: 6964047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical carmustine (BCNU) for patch/plaque mycosis fungoides.
    Zackheim HS
    Semin Dermatol; 1994 Sep; 13(3):202-6. PubMed ID: 7986689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epipodophyllotoxin (VP-16-213) in mycosis fungoides: A report from the Scandinavian mycosis fungoides study group.
    Molin L; Thomsen K; Volden G; Bergqvist-Karlsson A; Hallberg O; Hellbe L
    Acta Derm Venereol; 1979; 59(1):84-7. PubMed ID: 84480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.